ALK anticipates deficit despite record-quarter: "We decide if we generate profit"
Danish allergy group ALK recently presented the best Q1 interim report in the company's history. However, the CEO anticipates red numbers in the annual report as ALK continues to invest in the future.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism